The purpose of this study is to explore overall vision with BIOFINITY® ENERGYS™ contact lenses as compared to BIOFINITY® contact lenses after one week of wear.

Inclusion Criteria:

• Able to understand and sign an approved informed consent form (ICF);
• Successful wear of BIOFINITY® (spherical) (or private label) contact lenses in both eyes for a minimum of 5 days per week and 8 hours per day during the past 3 months;
• Best-corrected visual acuity (BCVA) 20/25 or better in each eye;
• Possess spectacles that provide a corrected visual acuity of 20/40 or better in both eyes (OU) and be willing to wear them (as needed);
• Currently using digital devices (computer, tablet, and/or smart phone) for a minimum of 5 days per week and 4 hours per day;
• Other protocol-specified inclusion criteria may apply.

Exclusion Criteria:

• Any anterior segment infection, inflammation, abnormality or disease that contraindicates contact lens wear;
• Any use of systemic or ocular medications for which contact lens wear could be contraindicated;
• Refractive, ocular, or intraocular surgery, as specified in the protocol;
• Current or history of eye injury or disorders, as specified in the protocol;
• Current or history of intolerance, hypersensitivity or allergy to any component of the study products;
• Habitual contact lens wear in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment;
• Use of topical ocular medications that would require instillation during contact lens wear;
• Other protocol-specified exclusion criteria may apply.

This analysis population includes all subjects/eyes exposed to any study lenses evaluated in this study (Safety Analysis Set).

Dispense through study completion, an average of 14 days

An Adverse Event (AE) was defined as any untoward medical occurrence, unintended disease or injury, or untoward clinical signs in subjects, users or other persons, whether or not related to the investigational medical device. Safety Analysis Set, based on treatment-specific exposure. AEs were obtained through solicited and spontaneous comments from subjects and through observations by the Investigator as outlined in the study protocol.